Cancer Biomarker Discovery via Low Molecular Weight Serum Proteome Profiling - Where Is the Tumor?
Davis M T, Auger P, Spahr C, Patterson S D
Purpose
Conclusion
Studies (2)
Purpose
The purpose of this study was to compare low molecular weight proteome patterns of paired serum and plasma samples collected from healthy and newly diagnosed prostate cancer patients at two collection centers.
Summary of Findings
Paired serum and plasma specimens were qualitatively different when analyzed by SELDI-TOF MS 30 minutes after blood collection, with multiple peaks unique to serum specimens observed that were later identified as fibrinopeptide A derivatives, indicating activation of the intrinsic coagulation cascade. Of note, comparison of serum and plasma samples collected via a secondary collection center yielded spectral complexity greater than predicted by the initial "in-house" study, although peaks were still consistent with products generated by the coagulation pathway for both serum and plasma samples.
Biospecimens
FluidSerumFluidPlasmaPreservation Types
FrozenDiagnoses
NormalNeoplasticCarcinomaPlatforms
ProteinSELDI-TOF MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Blood and blood products PlasmaSerum
Purpose
Summary of Findings
Biospecimens
FluidSerumPreservation Types
FrozenDiagnoses
NormalPlatforms
ProteinSELDI-TOF MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Storage Time at room temperature 120 min2 min30 min60 min90 min